Stay updated with breaking news from Benoit Barteau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eligo Bioscience, a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has announced a successful $30 million Series B funding round, led by Sanofi Ventures.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Biotech start-up Tridek-One focused on research and development of CD31 agonists to restore the immune balance, has closed a €16 million ($16. Click to read more...
Tridek-One SAS, which specializes in the R&D of CD31 agonists to restore immune balance, has closed a €16 million financing round.